earnings
XF
NASDAQ · XFOR
X4 Pharmaceuticals, Inc.
Healthcare · Biotechnology
$3.12
Down-$0.29 (-9.29%)
Updated Nov 17, 2026, 1:20 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.21M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $2.43 – $4.83
- Volume
- 501.34K
- Avg. volume
- 894.59K
Price performance · XFOR
XFOR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
XFOR closed at $3.12 after 20 trading sessions, up 13.45% for the selected period.
- Last close
- $3.12
- Period change
- +13.45%
- Period low
- $2.75
- Period high
- $3.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $3.20 | $3.20 | $2.975 | $3.12 | 501.34K |
| Nov 12, 2026 | $3.16 | $3.20 | $2.95 | $3.17 | 2.16M |
| Nov 11, 2026 | $3.27 | $3.36 | $3.175 | $3.23 | 776.24K |
| Nov 10, 2026 | $3.29 | $3.35 | $3.22 | $3.245 | 467.52K |
| Nov 9, 2026 | $3.24 | $3.46 | $3.18 | $3.33 | 891.55K |
| Nov 6, 2026 | $3.04 | $3.205 | $2.90 | $3.18 | 527.2K |
| Nov 5, 2026 | $3.07 | $3.13 | $2.895 | $3.07 | 607.59K |
| Nov 4, 2026 | $3.30 | $3.36 | $3.10 | $3.24 | 536.59K |
| Nov 3, 2026 | $3.37 | $3.42 | $3.135 | $3.17 | 631.07K |
| Nov 2, 2026 | $3.40 | $3.47 | $3.26 | $3.35 | 521.96K |
| Oct 30, 2026 | $3.33 | $3.41 | $3.19 | $3.35 | 706.24K |
| Oct 29, 2026 | $3.39 | $3.49 | $3.05 | $3.36 | 911.23K |
| Oct 28, 2026 | $3.24 | $3.36 | $3.14 | $3.35 | 534.95K |
| Oct 27, 2026 | $3.25 | $3.30 | $3.05 | $3.25 | 1.61M |
| Oct 26, 2026 | $3.26 | $3.30 | $3.14 | $3.25 | 701.65K |
| Oct 23, 2026 | $3.16 | $3.25 | $3.02 | $3.24 | 536.76K |
| Oct 22, 2026 | $2.99 | $3.2798 | $2.96 | $3.20 | 594.59K |
| Oct 21, 2026 | $3.02 | $3.12 | $2.875 | $3.01 | 406.91K |
| Oct 20, 2026 | $2.79 | $3.07 | $2.77 | $3.02 | 593.33K |
| Oct 19, 2026 | $2.60 | $2.82 | $2.58 | $2.75 | 602.98K |
Latest XFOR news
The latest Smart Investors Daily articles mentioning XFOR.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…

